Insights+: COVID-19 Healthcare News Monthly Updates – August 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.

83. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19

Aug 31, 2020 | Clinical Trial

82. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

Aug 31, 2020 | Clinical Trial

81. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Aug 31, 2020 | Clinical Trial

80. BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies

Aug 27, 2020 | Collaboration

79. Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect SARS-CoV-2 Infection

Aug 27, 2020 | Diagnostics

78. Laurent Pharmaceuticals Receives Approval from FDA to Initiate its COVID-19 Phase 2 Clinical Trial in the United States

Aug 27, 2020 | Regulatory

77. FDC Launches Two Variants of Favipiravir for COVID-19 in India

Aug 27, 2020 | Launch

76. Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program

Aug 26, 2020 | Clinical Trial

75. INTAS Develops COVID-19 Hyperimmune Globulin

Aug 26, 2020 | Regulatory

74. Capricor Therapeutics Report the US FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19

Aug 25, 2020 | Regulatory

73. AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19

Aug 25, 2020 | Clinical Trial

72. Bolder BioTechnology Announces Positive Preclinical Data for Use of BBT-032 to Inhibit Growth of the SARS-CoV-2 Virus

Aug 25, 2020 | Clinical Trial

71. Asalyxa Bio Launches with Novel Neutrophil-Targeting Drug Delivery Platform Technology and Lead Candidate, ASX-100 for ARDS and COVID-19 Patients

Aug 25, 2020 | Launch

70. Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19

Aug 25, 2020 | DigiHealth

69. EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics

Aug 25, 2020 | Collaboration

68. Mereo BioPharma Initiates P-Ib/II Clinical Trial with Alvelestat in COVID-19 Respiratory Disease

Aug 25, 2020 | Clinical Trial

67. Altimmune and the University of Alabama at Birmingham Report Potent Respiratory Mucosal T Cell Responses in Preclinical Study of Single-Dose Intranasal COVID-19 Vaccine Candidate, AdCOVID

Aug 25, 2020 | Clinical Trial

66. Partner Therapeutics Initiates Patient Enrollment in US Clinical Trial Evaluating Leukine (rhuGM-CSF, sargramostim) in COVID-19 Patients

Aug 25, 2020 | Clinical Trial

65. First Rapid Corona Antigen Test Approved for Clinical Study in Germany

Aug 25, 2020 | Diagnostics

64. Flexibility, Speed Enabling Actifio to Help in Pursuit of COVID-19 Treatments

Aug 25, 2020 | DigiHealth

63. Kedrion Biopharma and Kamada Continue Their Collaboration to Develop a New Anti-COVID Plasma-Based Treatment

Aug 25, 2020 | Collaboration

62. UNION therapeutics Completes Dosing of Healthy Volunteers with UNI911 (inhaled niclosamide) for COVID-19

Aug 25, 2020 | Clinical Trial

61. Medicure AGGRASTAT Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports

Aug 25, 2020 | Clinical Trial

60. Terumo and Cytosorbent Collaborate to Commercialize CytoSorb in Ten US COVID-19 Hotspot States

Aug 25, 2020 | Collaboration

59. Pfizer and BioNTech Plan for Regulatory Review of its COVID-19 Vaccine in October 2020

Aug 21, 2020 | Regulatory

58. BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19

Aug 20, 2020 | Collaboration

57. Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19

Aug 20, 2020 | Regulatory

56. Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Aug 20, 2020 | Launch

55. Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases

Aug 20, 2020 | DigiHealth

54. Finding Clues to a Successful Immune Response in the T Cells of Recovered COVID-19 Patients

Aug 21, 2020 | Clinical Trial

53. JanOne to Discuss JAN101 for Treatment of PAD and Potential Applications for COVID-19 Vascular Complications

Aug 21, 2020 | Clinical Trial

52. Co-Diagnostics Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test

Aug 20, 2020 | Diagnostics

51. Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients

Aug 20, 2020 | Clinical Trial

50. LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test

Aug 20, 2020 | Diagnostics

49. Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit

Aug 20, 2020 | Diagnostics

48. Regeneron Collaborates with Roche to Improve the Global Supply of REGN-COV2 Against COVID-19

Aug 19, 2020 | Collaboration

47. Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients

Aug 19, 2020 | Clinical Trial

46. Bio-Techne and Leica Biosystems Accelerates Disease Research with RNAscope COVID-19 Probes and the BOND RX

Aug 19, 2020 | Clinical Trial

45. Ampio Provides Update on COVID-19 Clinical Trial Activities

Aug 19, 2020 | Clinical Trial

44. Harbour BioMed, Utrecht University, Erasmus Medical Center, Viroclinics-DDL and Kiadis Pharma Collaborate to Develop Monoclonal Antibody for COVID-19

Aug 19, 2020 | Collaboration

43. NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial

Aug 18, 2020 | Grant

42. AstraZeneca Collaborates with mAbxience to Produce COVID-19 Vaccine in Latin America

Aug 18, 2020 | Collaboration

41. Vanda’s Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia

Aug 18, 2020 | Clinical Trial

40. BOLD-100 Significantly Outperforms Remdesivir Head-to-Head in SARS-CoV-2 (COVID-19) Model

Aug 17, 2020 | Clinical Trial

39. Pharming Announces the Publication of Data from a Compassionate Use Programme of RUCONEST in COVID-19 patients in a Peer-Reviewed Journal

Aug 17, 2020 | Clinical Trial

38. Novavax Collaborates with UK Government to Supply 60M Doses of NVX-CoV2373 to Combat COVID-19

Aug 14, 2020 | Collaboration

37. SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19 Vaccine

Aug 14, 2020 | Collaboration

36. EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine

Aug 14, 2020 | Collaboration

35. AstraZeneca to Initiate Production of its COVID-19 Vaccine Early in 2021

Aug 14, 2020 | Clinical Trial

34. Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Aug 13, 2020 | Clinical Trial

33. UNION Therapeutics Enters Option Agreement to Acquire Worldwide Exclusive License for COVID-19 Technologies Developed by TFF Pharmaceuticals

Aug 13, 2020 | Collaboration

32. Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

Aug 13, 2020 | Collaboration

31. Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

Aug 13, 2020 | Diagnostics

30. Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India

Aug 13, 2020 | Launch

29. Puradigm Announces Successful Tests of its Proactive Air and Surface Purification Technology in Deactivating SARS-CoV-2

Aug 10, 2020 | Diagnostics

28. New Study Proves Asclepius Meditec’s Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea

Aug 10, 2020 | Diagnostics

27. Vela Diagnostics’ ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA’s Emergency Use Authorization

Aug 07, 2020 | Diagnostics

26. Daiichi Sankyo Selected as Provider for Japanese Government’s “Emergent Initiative to Build Production Capacity for COVID-19 Vaccines’’

Aug 07, 2020 | Collaboration

25. Serum Institute to Produce COVID-19 Vaccines From AstraZeneca, Novavax

Aug 07, 2020 | Collaboration

24. Amarin Supports Study of Vascepa in Reducing Viral Upper Respiratory Infection

Aug 07, 2020 | Clinical Trial

23. Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment Acquires IP From World Leader in Respiratory Disease Medicine

Aug 06, 2020 | Collaboration

22. Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements

Aug 06, 2020 | Collaboration

21. Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B

Aug 06, 2020 | Collaboration

20. Glenmark Introduces FabiFlu (400mg) to Reduce Pill Burden of COVID-19 Treatment

Aug 06, 2020 | Launch

19. NIH Begins Clinical Trial Testing of Remdesivir + Interferon Beta-1a for COVID-19

Aug 06, 2020 | Clinical Trial

18. SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program

Aug 06, 2020 | Grant

17. Pfizer AND BioNTech To Supply BNT162 mRNA- based Vaccine Candidate in Canada

Aug 05, 2020 | Collaboration

16. Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

Aug 05, 2020 | Regulatory

15. Texas Startup Industrial Genetics Launches Surface and Wastewater Testing for the COVID-19 Virus (SARS-CoV-2)

Aug 05, 2020 | Launch

14. Zydus Cadila Announces Completion of Dosing in Phase I Clinical Trial of ZyCoV-D

Aug 05, 2020 | Clinical Trial

13. Centex Studies-Lake Charles to be the Only Site in SWLA to Run AstraZeneca COVID Vaccine Clinical Trial

Aug 05, 2020 | Clinical Trial

12. Celularity Announces the Activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19

Aug 05, 2020 | Grant

11. Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India

Aug 05, 2020 | Launch

10. BioNTech and Fosun Pharma Initiate Clinical Trial of BNT162b1 Against COVID-19 in China

Aug 05, 2020 | Clinical Trial

9. Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19

Aug 04, 2020 | Collaboration

8. Sanofi and GSK Receive $2.1B from the US Government to Supply 100M Doses of COVID-19 Vaccine

Aug 04, 2020 | Grant

7. Tiziana Life Sciences Expedite Clinical Development Plan for TZLS-501 for COVID-19

Aug 04, 2020 | Clinical Trial

6. Novavax Reports Positive Early Results for Experimental COVID-19 Vaccine NVX-CoV2373

Aug 04, 2020 | Clinical Trial

5. VERU-111 Suppresses Key Cytokines Responsible for Severe Acute Respiratory Distress Syndrome in COVID-19

Aug 04, 2020 | Clinical Trial

4. Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia

Aug 04, 2020 | Clinical Trial

3. Innovation Pharmaceuticals and US Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing

Aug 04, 2020 | Diagnostic

2. Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19

Aug 03, 2020 | Clinical Trial

1. Rival Drugmakers Launch Joint Trial of Medicines for COVID-19

Aug 03, 2020 | Clinical Trial